Inclisiran 300 mg Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 300 mg
Reference Brands: Leqvio (USA/EU)
Category: Heart Disorder
Inclisiran is a small interfering RNA (siRNA) therapy that works by reducing the production of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in the liver, which in turn increases the number of LDL receptors and helps remove more LDL cholesterol from the blood. It is used to lower LDL cholesterol in patients with high cholesterol (hypercholesterolemia) or atherosclerotic cardiovascular disease, especially when statins alone are insufficient or not tolerated.
Inclisiran — third party manufacturing & bulk supply
Inclisiran 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Inclisiran is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Inclisiran listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Inclisiran →Frequently Asked Questions
Inclisiran is used to lower low‑density lipoprotein cholesterol (LDL‑C) in adults with high cholesterol, including those with heterozygous familial hypercholesterolemia, and in people with atherosclerotic cardiovascular disease who need additional LDL‑C reduction beyond diet and maximally tolerated statin therapy.
Inclisiran is a synthetic small interfering RNA (siRNA), a chemically modified double‑stranded oligonucleotide that targets mRNA for the protein PCSK9 in liver cells, preventing its production.
The trade name of Inclisiran is Leqvio.
Inclisiran (Leqvio) is manufactured and marketed by Novartis.
The generic name is Inclisiran.
The brand name is Leqvio.
Inclisiran is produced by Novartis under global regulatory approvals.
Related Products
Lovastatin
Strength:
10 mg, 20 mg, 40 mg
Form: Tablets
Reference Brands: Mevacor (USA/EU), Altoprev (USA/EU)
View DetailsLomitapide
Strength:
5 mg, 10 mg, 20 mg, 30 mg
Form: Capsules
Reference Brands: Juxtapid(USA), Lojuxta(EU)
View DetailsEzetimibe / Atorvastatin
Strength:
10/10 mg, 10/20 mg, 10/40 mg, 10/80 mg
Form: Tablets
Reference Brands: Liptruzet (USA), Atozet (EU), Aztor EZ (India)
View DetailsIcosapent Ethyl
Strength:
1 g
Form: Capsules
Reference Brands: Vascepa (USA), Vazkepa (EU/UK)
View DetailsIsoxsuprine Hydrochloride Tablet
Strength:
20 mg
Form: Tablets
Reference Brands: Duvadilan (EU/India)
View DetailsNitroglycerin Controlled Release Tablets
Strength:
2.6 mg, 6.5 mg, 9 mg
Form: Tablets
Reference Brands: Various Indian Brand Available
View DetailsNitroglycerin Sublingual Tablet
Strength:
0.5 mg, 0.3 mg, 0.4 mg, 0.6 mg
Form: Tablets
Reference Brands: Nitrostat (USA, EU, LATAM), Glyceryl Trinitrate Sublingual (EU, UK, India
View DetailsRosuvastatin & Fenofibrate Tablet
Strength:
(10mg + 160mg),(20mg + 160mg)
Form: Tablets
Reference Brands: Various Indian Brand Available
View DetailsQuick Response Guaranteed | Verified Suppliers